Skip to contentX
Xenetic Biosciences, Inc.
X
XBIOXenetic Biosciences, Inc. Q3 2018 · 10-Q
Revenue$0.00$0.00−100.0% vs Q3 2017 Net Income-$1.81M-$1.81MN/M vs Q3 2017 EPS Diluted-$2.31-$2.31N/M vs Q3 2017 Operating Income-$1,814,887N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,668,136N/M ended Sep 30, 2018 · filed Nov 9, 2018 · 40 d after period end